The Week Ahead: COS...
Health Care: Drugs
GlaxoSmithKline PLC (GSK: NYSE)
$52.97 0.24 | 0.46%
05/24/13 - 04:01 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with GSK
- Portfolio NameUser Type
- Usersamuel sandler kosher sausage
- ContributorStocks Rising On Unusual Vo...
- ProBill Miller - Legg Mason Ca...
- ProKen Fisher - Fisher Investm...
- Usercurrent holdings
- Contributor7 Big-Pharma Stocks With Un...
- Contributor10 Dividend Stocks Held by ...
- UserKAREL VON ZOETE
- UserMARIA DEL HUERTO
- ContributorHighest-Yielding Drug Stocks
Latest GSK Headlines from TheStreet
- GE Reports 16% Jump in Profit
04.19.13 | 11:04 am - GE Profit Jumps 16%: Ahead of the Ticker 04.19.13 | 08:04 am
- Cramer Talks Abbott & Glaxo 04.17.13 | 03:04 pm
- GlaxoSmithKline Reaches New 52-Week High (GSK) 04.17.13 | 02:04 pm
- GlaxoSmithKline Rises On Unusually High Volume (GSK) 04.15.13 | 01:04 pm
- Mad Money Uncovered: Merck and the Pharma Laggards 04.15.13 | 12:04 pm
- 5 Stocks Pulling The Drugs Industry Downward 04.12.13 | 01:04 pm
- Sarepta Fans: A Single Data Slide Raises Questions About Glaxo's DMD Drug 04.12.13 | 10:04 am
- 4 Buy-Rated Dividend Stocks 04.11.13 | 11:04 am
- Cramer's Top Stock Picks: GSK NBL ORCL 04.11.13 | 06:04 am
Press Releases for GSK
- FDA Advisory Committee Recommends Approval Of BREOâ¿¢ ELLIPTAâ¿¢ For The Treatment Of COPD - PR Newswire 04.17.13 | 05:04 pm
- GlaxoSmithKline, Triangle Community Foundation Issue Call For Applications Totaling $400,000 In GSK IMPACT Awards - PR Newswire 04.17.13 | 11:04 am
- GlaxoSmithKline Issues Call For Applications Totaling $400,000 In GSK IMPACT Awards - PR Newswire 04.17.13 | 11:04 am
- GlaxoSmithKline And Liberty Property Trust/Synterra Partners Transform The Work Environment With The Opening Of Five Crescent Drive Today - PR Newswire 04.06.13 | 06:04 pm
- GlaxoSmithKline And Liberty Property Trust/Synterra Partners Transform The Work Environment With The Opening Of Five Crescent Drive - PR Newswire 04.05.13 | 10:04 am
- Texas A&M System And GlaxoSmithKline Receive U.S. Government Approval To Establish Influenza Vaccine Facility In Texas - PR Newswire 03.26.13 | 11:03 am
- Americans Rate Themselves And Their Communities As Healthy, Despite Research Showing The Opposite - PR Newswire 03.06.13 | 09:03 am
- GlaxoSmithKline Progresses Multi-city Discussion Focused On Improving The Health Of US Communities - PR Newswire 02.06.13 | 09:02 am
- FDA Approves GlaxoSmithKline's Four-strain Seasonal Influenza Vaccine For Use In The U.S. - PR Newswire 12.17.12 | 10:12 am
- GSK Receives FDA Approval For Raxibacumab Anti-toxin For The Treatment Of Inhalational Anthrax - PR Newswire 12.14.12 | 05:12 pm
Partner Headlines for GSK
- Muscular Dystrophy Drug Succeeds, Sarepta Buyers Flood In - Seeking Alpha 04.11.13 | 09:04 am
- Parexel Grows Earnings With Big Pharma Partnerships - Investor's Business Daily 04.04.13 | 02:04 pm
- Curing Parkinson's: The Alternative Approach - Is There Money To Be Made? - Seeking Alpha 04.04.13 | 09:04 am
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- 5 Dividends Stocks From Billionaire Ken Fisher - Seeking Alpha 03.28.13 | 09:03 am
- Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind - Seeking Alpha 03.25.13 | 09:03 am
- Top 9 March Healthcare Dogs Mark 3.4% To 28.7% Gains - Seeking Alpha 03.23.13 | 04:03 am
- Valeant Earnings, Sales Top Estimates; Street Shrugs - Investor's Business Daily 02.28.13 | 05:02 pm
- Roche Breast Cancer Drug To Succeed Herceptin - Investor's Business Daily 02.22.13 | 04:02 pm
- GlaxoSmithKline PLC (GSK) Ex-Dividend Date Scheduled for February 20, 2013 - NASDAQ 02.15.13 | 02:02 pm
